Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Antipsychotic treatment in breast cancer patients.

Rahman T, Clevenger CV, Kaklamani V, Lauriello J, Campbell A, Malwitz K, Kirkland RS.

Am J Psychiatry. 2014 Jun 1;171(6):616-21. doi: 10.1176/appi.ajp.2013.13050650.

PMID:
24880509
[PubMed - in process]
2.

Predicting benefit from imatinib: are we close?

Gandhi MD, Kaklamani VG.

Leuk Lymphoma. 2014 Apr 22. [Epub ahead of print] No abstract available.

PMID:
24684225
[PubMed - as supplied by publisher]
3.

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.

Jackson SA, Davis AA, Li J, Yi N, McCormick SR, Grant C, Fallen T, Crawford B, Loranger K, Litton J, Arun B, Vande Wydeven K, Sidani A, Farmer K, Sanders M, Hoskins K, Nussbaum R, Esserman L, Garber JE, Kaklamani VG; Northwestern Cancer Genetics Group.

Cancer. 2014 May 15;120(10):1557-64. doi: 10.1002/cncr.28577. Epub 2014 Feb 12.

PMID:
24522996
[PubMed - indexed for MEDLINE]
4.

Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer.

Reddy SM, Sadim M, Li J, Yi N, Agarwal S, Mantzoros CS, Kaklamani VG.

Br J Cancer. 2013 Aug 20;109(4):872-81. doi: 10.1038/bjc.2013.441. Epub 2013 Aug 6.

PMID:
23922112
[PubMed - indexed for MEDLINE]
5.

Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative.

Kaklamani VG, Hoffmann TJ, Thornton TA, Hayes G, Chlebowski R, Van Horn L, Mantzoros C.

Breast Cancer Res Treat. 2013 Jun;139(2):461-8. doi: 10.1007/s10549-013-2546-6. Epub 2013 Apr 30.

PMID:
23624817
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab.

Schwartzberg LS, Tauer KW, Hermann RC, Makari-Judson G, Isaacs C, Beck JT, Kaklamani V, Stepanski EJ, Rugo HS, Wang W, Bell-McGuinn K, Kirshner JJ, Eisenberg P, Emanuelson R, Keaton M, Levine E, Medgyesy DC, Qamar R, Starr A, Ro SK, Lokker NA, Hudis CA.

Clin Cancer Res. 2013 May 15;19(10):2745-54. doi: 10.1158/1078-0432.CCR-12-3177. Epub 2013 Feb 26.

PMID:
23444220
[PubMed - indexed for MEDLINE]
Free Article
7.

Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.

Kumthekar P, Grimm SA, Avram MJ, Kaklamani V, Helenowski I, Rademaker A, Cianfrocca M, Gradishar W, Patel J, Mulcahy M, McCarthy K, Raizer JJ.

J Neurooncol. 2013 Apr;112(2):247-55. doi: 10.1007/s11060-013-1055-0. Epub 2013 Jan 25.

PMID:
23354655
[PubMed - indexed for MEDLINE]
8.

A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.

Bao Y, Giovannucci EL, Kraft P, Stampfer MJ, Ogino S, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, Rifai N, Pollak MN, Cochrane BB, Kaklamani V, Lin JH, Manson JE, Fuchs CS, Wolpin BM.

J Natl Cancer Inst. 2013 Jan 16;105(2):95-103. doi: 10.1093/jnci/djs474. Epub 2012 Dec 14.

PMID:
23243202
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer.

Gradishar WJ, Kaklamani V, Sahoo TP, Lokanatha D, Raina V, Bondarde S, Jain M, Ro SK, Lokker NA, Schwartzberg L.

Eur J Cancer. 2013 Jan;49(2):312-22. doi: 10.1016/j.ejca.2012.08.005. Epub 2012 Sep 3.

PMID:
22954665
[PubMed - indexed for MEDLINE]
10.

The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.

Economopoulou P, Kaklamani VG, Siziopikou K.

Oncologist. 2012;17(11):1394-401. doi: 10.1634/theoncologist.2012-0163. Epub 2012 Aug 31. Review.

PMID:
22941971
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Targeting angiogenesis in metastatic breast cancer.

Reddy S, Raffin M, Kaklamani V.

Oncologist. 2012;17(8):1014-26. doi: 10.1634/theoncologist.2012-0043. Epub 2012 Jul 27.

PMID:
22843553
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Diabetes, metformin, and breast cancer in postmenopausal women.

Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T, Ipp E, Kaklamani VG, Vitolins M, Wallace R, Gunter M, Phillips LS, Strickler H, Margolis K, Euhus DM.

J Clin Oncol. 2012 Aug 10;30(23):2844-52. doi: 10.1200/JCO.2011.39.7505. Epub 2012 Jun 11.

PMID:
22689798
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Metabolic syndrome and triple-negative breast cancer: a new paradigm.

Davis AA, Kaklamani VG.

Int J Breast Cancer. 2012;2012:809291. doi: 10.1155/2012/809291. Epub 2011 Oct 15.

PMID:
22295251
[PubMed]
Free PMC Article
14.

Global experience with ixabepilone in breast cancer.

Kaklamani VG, Xu BH, Gomez HL.

Expert Rev Anticancer Ther. 2011 May;11(5):683-92. doi: 10.1586/era.11.41. Review.

PMID:
21554041
[PubMed - indexed for MEDLINE]
15.

The role of the fat mass and obesity associated gene (FTO) in breast cancer risk.

Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, Tofilon S, Agarwal S, Pasche B, Mantzoros C.

BMC Med Genet. 2011 Apr 13;12:52. doi: 10.1186/1471-2350-12-52.

PMID:
21489227
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.

Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B.

Metabolism. 2011 Sep;60(9):1234-43. doi: 10.1016/j.metabol.2011.01.005. Epub 2011 Mar 12.

PMID:
21397927
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib.

Kaklamani VG, Siziopikou K, Scholtens D, Lacouture M, Gordon J, Uthe R, Meservey C, Hansen N, Khan SA, Jeruss JS, Bethke K, Cianfrocca M, Rosen S, Von Roenn J, Wayne J, Parimi V, Jovanovic B, Gradishar W.

Breast Cancer Res Treat. 2012 Apr;132(3):833-42. doi: 10.1007/s10549-011-1411-8. Epub 2011 Feb 27.

PMID:
21359953
[PubMed - indexed for MEDLINE]
18.

Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk.

Yi N, Kaklamani VG, Pasche B.

Ann Hum Genet. 2011 Jan;75(1):90-104. doi: 10.1111/j.1469-1809.2010.00605.x. Epub 2010 Sep 15.

PMID:
20846215
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Lessons learned from genetic testing.

Esserman L, Kaklamani V.

JAMA. 2010 Sep 1;304(9):1011-2. doi: 10.1001/jama.2010.1263. No abstract available.

PMID:
20810382
[PubMed - indexed for MEDLINE]
20.

Lapatinib and breast cancer: current indications and outlook for the future.

Moreira C, Kaklamani V.

Expert Rev Anticancer Ther. 2010 Aug;10(8):1171-82. doi: 10.1586/era.10.113. Review.

PMID:
20735304
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk